Literature DB >> 7981747

The structural and functional diversity of dystrophin.

A H Ahn1, L M Kunkel.   

Abstract

Duchenne and Becker muscular dystrophies are caused by defects of the dystrophin gene. Expression of this large X-linked gene is under elaborate transcriptional and splicing control. At least five independent promoters specify the transcription of their respective alternative first exons in a cell-specific and developmentally controlled manner. Three promoters express full-length dystrophin, while two promoters near the C terminus express the last domains in a mutually exclusive manner. Six exons of the C terminus are alternatively spliced, giving rise to several alternative forms. Genetic, biochemical and anatomical studies of dystrophin suggest that a number of distinct functions are subserved by its great structural diversity. Extensive studies of dystrophin may lead to an understanding of the cause and perhaps a rational treatment for muscular dystrophy.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7981747     DOI: 10.1038/ng0493-283

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  142 in total

1.  Binding of dystrophin's tandem calponin homology domain to F-actin is modulated by actin's structure.

Authors:  A Orlova; I N Rybakova; E Prochniewicz; D D Thomas; J M Ervasti; E H Egelman
Journal:  Biophys J       Date:  2001-04       Impact factor: 4.033

2.  Characterization of Chlamydomonas reinhardtii zygote-specific cDNAs that encode novel proteins containing ankyrin repeats and WW domains.

Authors:  H Kuriyama; H Takano; L Suzuki; H Uchida; S Kawano; H Kuroiwa; T Kuroiwa
Journal:  Plant Physiol       Date:  1999-03       Impact factor: 8.340

3.  ERG phenotype of a dystrophin mutation in heterozygous female carriers of Duchenne muscular dystrophy.

Authors:  K M Fitzgerald; G W Cibis; A H Gettel; R Rinaldi; D J Harris; R A White
Journal:  J Med Genet       Date:  1999-04       Impact factor: 6.318

4.  Alternative splicing of agrin regulates its binding to heparin alpha-dystroglycan, and the cell surface.

Authors:  J J O'Toole; K A Deyst; M A Bowe; M A Nastuk; B A McKechnie; J R Fallon
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

5.  Tissue- and case-specific retention of intron 40 in mature dystrophin mRNA.

Authors:  Atsushi Nishida; Maki Minegishi; Atsuko Takeuchi; Emma Tabe Eko Niba; Hiroyuki Awano; Tomoko Lee; Kazumoto Iijima; Yasuhiro Takeshima; Masafumi Matsuo
Journal:  J Hum Genet       Date:  2015-04-02       Impact factor: 3.172

6.  Bcl-2 overexpression prevents calcium overload and subsequent apoptosis in dystrophic myotubes.

Authors:  Olivier Basset; François-Xavier Boittin; Christian Cognard; Bruno Constantin; Urs T Ruegg
Journal:  Biochem J       Date:  2006-04-15       Impact factor: 3.857

7.  Cardiac syntrophin isoforms: species-dependent expression, association with dystrophin complex and subcellular localization.

Authors:  Yuko Iwata; Munekazu Shigekawa; Shigeo Wakabayashi
Journal:  Mol Cell Biochem       Date:  2005-01       Impact factor: 3.396

8.  Dystrophin Dp71 in PC12 cell adhesion.

Authors:  Jose Arturo Enríquez-Aragón; Joel Cerna-Cortés; Mario Bermúdez de León; Francisco García-Sierra; Everardo González; Dominique Mornet; Bulmaro Cisneros
Journal:  Neuroreport       Date:  2005-02-28       Impact factor: 1.837

9.  Dystrophin Dp71f associates with the beta1-integrin adhesion complex to modulate PC12 cell adhesion.

Authors:  Joel Cerna; Doris Cerecedo; Arturo Ortega; Francisco García-Sierra; Federico Centeno; Efrain Garrido; Dominique Mornet; Bulmaro Cisneros
Journal:  J Mol Biol       Date:  2006-08-01       Impact factor: 5.469

Review 10.  Multiple pathogenetic mechanisms in X linked dilated cardiomyopathy.

Authors:  N Cohen; F Muntoni
Journal:  Heart       Date:  2004-08       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.